Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-03 Sale |
2022-10-05 4:40 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $19.64 | $61,395 | 97,472 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-19 4:40 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
4,168 | $21.01 | $87,570 | 100,598 (Direct) |
View |
| 2022-09-07 Sale |
2022-09-09 4:20 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
1,042 | $21 | $21,884 | 104,766 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-06 4:20 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,126 | $18.59 | $58,112 | 107,144 (Direct) |
View |
| 2022-07-26 Sale |
2022-07-29 4:26 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
1,152 | $20.7 | $23,847 | 6,102 (Direct) |
View |
| 2022-07-13 Sale |
2022-07-15 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,700 | $20.96 | $119,455 | 12,536 (Direct) |
View |
| 2022-05-02 Sale |
2022-05-04 5:01 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,247 | $20.1 | $65,252 | 107,598 (Direct) |
View |
| 2022-04-18 Sale |
2022-04-21 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,664 | $25.81 | $146,188 | 110,845 (Direct) |
View |
| 2022-04-18 Purchase |
2022-04-18 5:39 pm |
Crinetics Pharmaceuticals Inc. | CRNX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
157,515 | $22.22 | $3,499,983 | 5,321,032 (Indirect) |
View |
| 2022-04-13 Sale |
2022-04-15 6:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
138,643 | $26.83 | $3,719,625 | 1,059,205 (Indirect Direct) |
View |
| 2022-04-05 Sale |
2022-04-07 5:58 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
21,357 | $25.34 | $541,225 | 1,197,848 (Indirect Direct) |
View |
| 2022-04-04 Sale |
2022-04-06 7:08 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
9,000 | $23.97 | $215,762 | 116,509 (Direct) |
View |
| 2022-03-31 Sale |
2022-04-01 5:39 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
8,328 | $21.43 | $178,475 | 125,509 (Direct) |
View |
| 2022-03-15 Sale |
2022-03-17 4:33 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $18.94 | $59,150 | 133,837 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
9,000 | $19.88 | $178,920 | 242,395 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 9:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $19.73 | $61,617 | 213,960 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-17 4:34 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $18.64 | $58,213 | 123,583 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
13,411 | $17.83 | $239,085 | 172,045 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 4:30 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,123 | $18.79 | $58,681 | 126,706 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-10-10 Option Award |
2022-10-11 4:35 pm |
N/A 2032-10-09 |
Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Development Officer |
242,500 | $0 | 242,500 (Direct) |
View |
| 2022-05-20 Other |
2022-09-06 4:20 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
1,336 | $11.02 | 107,144 (Direct) |
View |
| 2022-05-20 Other |
2022-07-29 4:26 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
1,152 | $17.44 | 6,102 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,700 | $1.45 | 12,536 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 4:30 pm |
N/A 2027-11-05 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,700 | $0 | 12,536 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:48 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDALL Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:47 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
8,750 | $0 | 8,750 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:46 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:46 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:46 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:45 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
4,375 | $0 | 4,375 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:44 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-03-11 Option Award(A) |
2022-04-04 7:09 pm |
N/A 2032-03-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-01-03 Option Award(A) |
2022-04-04 7:08 pm |
N/A 2031-12-31 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-03-11 Option Award |
2022-03-14 5:25 pm |
N/A 2032-03-10 |
Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-10 4:51 pm |
N/A 2032-03-09 |
Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
302,600 | $0 | 1,468,405 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
28,050 | $0 | 28,050 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
110,500 | $0 | 172,618 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
79,350 | $0 | 242,395 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
93,500 | $0 | 213,960 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 9:00 pm |
N/A 2032-02-27 |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
80,750 | $0 | 89,061 (Direct) |
View |
| 2021-05-20 Ownership |
2022-02-04 4:30 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO |
1,927 | $11.02 | 64,045 (Direct) |
View |
| 2021-11-19 Ownership |
2022-02-04 4:26 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
785 | $11.02 | 186,241 (Direct) |
View |